Literature DB >> 11210824

Can gene therapy overcome the problem of hypoxia in radiotherapy?

O Greco1, A V Patterson, G U Dachs.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 11210824     DOI： 10.1269/jrr.41.201

Source DB:  PubMed          Journal:  J Radiat Res        ISSN： 0449-3060            Impact factor:   2.724


× No keyword cloud information.
  7 in total

Review 1.  Targeting metabolic transformation for cancer therapy.

Authors:  Daniel A Tennant; Raúl V Durán; Eyal Gottlieb
Journal:  Nat Rev Cancer       Date:  2010-03-19       Impact factor: 60.716

2.  Development of a novel interferon-α2b gene construct with a repetitive hypoxia-inducible factor binding site and its suppressive effects on human renal cell carcinoma cell lines in vitro.

Authors:  Naotaka Fukui; Yukio Kageyama; Yotsuo Higashi; Kazunori Kihara; Shinae Kizaka-Kondoh; Masahiro Hiraoka; Toshiaki Shinojima; Kenjiro Suzuki; Mototsugu Oya
Journal:  Int J Clin Oncol       Date:  2013-06-06       Impact factor: 3.402

3.  Anti-apoptotic role of HIF-1 and AP-1 in paclitaxel exposed breast cancer cells under hypoxia.

Authors:  Lionel Flamant; Annick Notte; Noelle Ninane; Martine Raes; Carine Michiels
Journal:  Mol Cancer       Date:  2010-07-13       Impact factor: 27.401

4.  A decade of progress in cancer research.

Authors:  Christna Chap; Jigisha Patel
Journal:  BMC Cancer       Date:  2011-11-30       Impact factor: 4.430

5.  Imaging and Targeting of the Hypoxia-inducible Factor 1-active Microenvironment.

Authors:  Shinae Kizaka-Kondoh; Shotaro Tanaka; Masahiro Hiraoka
Journal:  J Toxicol Pathol       Date:  2009-07-07       Impact factor: 1.628

Review 6.  Hypoxia-inducible tumour-specific promoters as a dual-targeting transcriptional regulation system for cancer gene therapy.

Authors:  Bita Javan; Majid Shahbazi
Journal:  Ecancermedicalscience       Date:  2017-07-06

7.  Adenovirus-mediated hypoxia-targeting cytosine deaminase gene therapy enhances radiotherapy in tumour xenografts.

Authors:  J Liu; H Harada; M Ogura; T Shibata; M Hiraoka
Journal:  Br J Cancer       Date:  2007-05-22       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.